Austin, July 10, 2025 (GLOBE NEWSWIRE) -- Smart Inhalers Market Size & Growth Analysis:
According to SNS Insider, the global Smart Inhalers Market was valued at USD 1.63 billion in 2023 and is projected to reach USD 5.30 billion by 2032, growing at a CAGR of 14.01% during the forecast period (2024–2032). The United States was the largest market contributor in 2023, accounting for USD 0.57 billion, and is forecasted to grow to USD 1.76 billion by 2032. This growth is fueled by a robust digital health infrastructure, increasing awareness of respiratory health, and the adoption of connected devices for remote disease management.
Get a Sample Report of Smart Inhalers Market@ https://www.snsinsider.com/sample-request/3488
Market Overview
Smart inhalers represent a technological leap in respiratory care, combining drug delivery with digital tracking for asthma and COPD management. These devices integrate sensors and mobile apps to monitor medication usage, send personalized alerts, and track adherence. This innovation is particularly critical as improper inhaler use continues to drive unnecessary hospitalizations and healthcare costs.
With the rising aging population, urban air pollution, and increasing healthcare investments in emerging markets, the adoption of smart inhalers is on the rise. Strategic collaborations between pharmaceutical and health-tech companies, government-backed reimbursement programs, and a shift toward telehealth are accelerating global penetration. The transition to value-based healthcare further supports the integration of these devices into mainstream respiratory therapy.
Major Players Analysis Listed in this Report are:
- Presspart Verwaltungs GmbH – eMDI
- Personal Air Quality Systems Pvt Ltd – Respiratory Monitoring Device
- COHERO Health Inc. (AptarGroup, Inc.) – HeroTracker Sense
- Cognita Labs – CapMedic
- Adherium – Hailie Smart Inhaler
- Amiko Digital Health Limited – Respiro
- Teva Pharmaceuticals Industries Ltd. – ProAir Digihaler, AirDuo Digihaler
- Propeller Health (ResMed) – Propeller Sensor
- Novartis AG – Enerzair Breezhaler, Breezhaler
- Pneuma Respiratory Inc. – Pneuma Inhaler
- 3M – 3M Intelligent Inhaler
- AireHealth, Inc. – AireHealth Smart Inhaler
- FindAir Sp. z o.o – FindAir ONE
- Sanofi – Smart Inhaler Device
- Sana Health – Digital Respiratory Device
- Cureatr – Connected Inhaler Solution
- Boehringer Ingelheim – Respimat
- Cipla – Cipla Smart Inhaler
- MediSprout – Remote Monitoring Inhaler
- AeroFuck – Smart Inhaler Technology
- GlaxoSmithKline – Ellipta Smart Inhaler
- Mylan – Smart Respiratory Device
- Incube Labs – Digital Inhaler Platform
- Rugged Science – Connected Inhaler System
Smart Inhalers Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.63 billion |
| Market Size by 2032 | US$ 5.30 billion |
| CAGR | CAGR of 14.01% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Regional Analysis | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
Segment Analysis
By Type
MDIs (Metered Dose Inhalers) held the largest market share in 2023, due to existing clinical experiences, ease of use, sensor readiness, and robustness to create various concepts of sensor-based smart modules. They are widely prescribed for the treatment of both asthma and COPD, particularly in the elderly.
DPIs are the fastest growing of these, with their breath-actuated devices and zero propellant content, as well as increasing interest among users in terms of both environmental and pediatric acceptability.
By Indication
In 2023, the COPD segment dominated the market, with a share of 50.7%, as COPD is highly prevalent across the globe, and it requires continuous monitoring to prevent worsening symptoms. And asthma is the fastest growing indication, thanks to early diagnosis, growth in the number of paediatric cases, and more digitally savvy younger patients and carers.
By Distribution Channel
Hospitals' pharmacies segment dominates the global market in 2023, with a strong doctor–patient relationship and dependence on hospital technology procurement. Moreover, the fastest growing pharmacies are primarily online, and for ease, digital prescriptions, home delivery, and the newfound uptick in telemedicine.
By End Use
The largest share of spending, or 51.5% in 2023, was at hospitals, driven by higher patient volumes and emergency inhaler use, and bundled digital care approaches. The care is the fastest growing segment induced by such demand for remote monitoring, the treatment at home of chronicle disease, and the increasing preference for individualized treatment.
For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ https://www.snsinsider.com/request-analyst/3488
Smart Inhalers Market Segmentation
By Type
- Dry Powdered Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
By Indication
- Asthma
- COPD
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By End Use
- Hospitals
- Homecare Settings
- Others
Regional Analysis
North America was a prominent smart inhalers market in 2023, owing to well-established reimbursement policies, higher disease awareness, and the presence of large industry players in the region.
The fastest growing market is the Asia Pacific, driven by higher prevalence of respiratory diseases associated with pollution, increasing disposable income, growing access to healthcare, and government initiatives for digital health in the likes of India, China, and South Korea.
Recent Developments
- In October 2024, Modivcare Inc. and its subsidiaries, VRI and Higi Care, collaborated with Tenovi for the incorporation of Adherium’s Hailie Smart Inhalers in remote patient monitoring programs.
- In June 2024, Aseptika introduced PUFFClicker3, an all-in-one dose counter supporting 101 inhalers to improve monitoring of usage and adherence to therapies.
- In May 2024, ResMed introduces the first-ever smart inhaler connected software platform, “AirAssist,” for integrated respiratory care, to the Australian market.
Buy a Single-User PDF of Smart Inhalers Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/3488
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Respiratory Diseases (2023)
5.2 Smart Inhaler Prescription Trends (2023), by Region
5.3 Technological Advancements and Integration Trends (2023-2032)
5.4 Regulatory and Compliance Trends (2023-2032)
5.5 Patient Adoption and Adherence Rates (2023)
6. Competitive Landscape
7. Smart Inhalers Market by Type
8. Smart Inhalers Market by Indication
9. Smart Inhalers Market by Distribution Channel
10. Smart Inhalers Market by End Use
11. Regional Analysis
12. Company Profiles
13. Use Cases and Best Practices
14. Conclusion
Related Reports
Inhalable Drug Delivery Systems Market Report
Digital Therapeutics Market Report
Respiratory Devices Market Report
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
